The ICR was established in June 2016 through an innovative partnership between Colorado State University – Pueblo, the state of Colorado, and Pueblo County.
With initial funding support from Pueblo County and the state of Colorado, the ICR is the nation’s first multi-disciplinary cannabis research center at a regional, comprehensive institution. The primary function of the Institute is the generation of knowledge that contributes to science, medicine, and society through investigation of the benefits and risks associated with cannabis. Research findings are used to translate discoveries into innovative applications that improve lives.
For more information about ICR, visit csupueblo.edu/institute-of-cannabis-research.
The ICR was established in June 2016 through an innovative partnership between Colorado State University – Pueblo, the state of Colorado, and Pueblo County.
With initial funding support from Pueblo County and the state of Colorado, the ICR is the nation’s first multi-disciplinary cannabis research center at a regional, comprehensive institution. The primary function of the Institute is the generation of knowledge that contributes to science, medicine, and society through investigation of the benefits and risks associated with cannabis. Research findings are used to translate discoveries into innovative applications that improve lives.
For more information about ICR, visit csupueblo.edu/institute-of-cannabis-research.
MECHOULAM
LECTURE
Esther Shohami, PhD received her doctorate in Physiology from the Hebrew University (HU), Jerusalem, Israel and did her post-doc at MC-Gill University in Montreal, Canada. She later joined the HU School of Pharmacy at the faculty of medicine and is currently a Professor Emerita in Pharmacology at the HU Institute for Drug Research. Between 2006 - 2011 she served as the Dean of students at her University, and between 2012-2014 as the president of the Israel Society for Neuroscience. She is a member of the executive board of the International Neurotrauma Society (INTS) and serves on the editorial boards of J. Neurotrauma. She also served as a council member of the US National Neurotrauma Society and on the editorial board of J. CBF & M.
Prof. Shohami has published more than 220 articles, reviews, and book chapters. Her research is focused on experimental traumatic brain injury (TBI) in rodents and addresses mechanisms of injury (e.g, inflammation, oxidative stress, the glutamate NMDAR) and endogenous neuroprotection (e.g. endocannabinoids and heat-acclimation induced preconditioning). Currently, her work focuses on the effects of TBI on cognitive functions and on mechanisms involved in ameliorating these TBI-induced deficits. She also studies the involvement of the endocannabinoid system in the pathophysiology and rehabilitation after TBI and is involved in developing cannabinoid-like novel drugs for TBI.
